We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:IMVT
​
​
logo

Immunovant (IMVT)

Nasdaq • IMVT • US45258J1025

35.70Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 26, 2026, ORTEX estimated 19.8% of free float sold short, 12.9 days to cover, cost to borrow 0.37%. Sign up for live short interest data.

Market Cap

7.39b USD | # 1989 in US

Volume

1.44m shares | 50.52m USD

Shares Outstanding

206.55m

Free Float Shares

44.43% | 91.77m

News

IMVT key data

Immunovant (Nasdaq: IMVT) has a market capitalization of $7.39B. Last close $35.70 (as of 2026-11-11); 52-week range $21.86 to $45.42. ORTEX data as of 2026-10-26: short interest was 19.84% of free float, 12.9 days to cover and the average cost to borrow was 0.37%. Sign up for live short interest data.

  • IMVT news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.